Attitudes and Knowledge About Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Brazilian Infectious Disease Physicians

AIDS Res Hum Retroviruses. 2020 Dec;36(12):1047-1053. doi: 10.1089/AID.2019.0281. Epub 2020 Aug 3.

Abstract

The objective was to describe levels and predictors of knowledge, attitudes, and willingness to prescribe pre-exposure prophylaxis (PrEP) among Brazilian Infectious Disease (ID) Physicians. The design was a cross-sectional study. We collected information on demographics and attitudes/knowledge about PrEP using an anonymous electronic survey. Willingness to prescribe PrEP, fear of adherence issues, and concerns about risk compensation were addressed in three case vignettes that varied by a single characteristic (i.e., by gender identity, drug use, and socioeconomic status) randomly assigned to physicians. Three hundred seventy ID physicians responded to the survey. Although most identified as informed/well informed about PrEP (75%) and believed PrEP availability to be necessary (38%), concerns with adherence (49%), side effects (38%), risk compensation (28%), and increase in sexually transmitted infection incidence (38%) were raised. We found no statistically significant differences in willingness to prescribe PrEP and concerns around risk compensation across the three case vignettes. ID physicians who declared having a religion reported more concerns about risk compensation compared to those self-identified as atheists (72% vs. 46%, p < .001). Most Brazilian ID physicians reported a positive attitude toward PrEP. Patients' gender identity, drug use, and socioeconomic status were not associated with willingness to prescribe PrEP. However, ID physicians who declared having a religion were more frequently concerned about risk compensation among PrEP users, suggesting that personal beliefs can influence PrEP implementation.

Keywords: HIV infections; attitudes; health knowledge; implementation science; practice; pre-exposure prophylaxis.

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Brazil
  • Cross-Sectional Studies
  • Female
  • Gender Identity
  • HIV
  • HIV Infections* / drug therapy
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Male
  • Physicians*
  • Practice Patterns, Physicians'
  • Pre-Exposure Prophylaxis*
  • Surveys and Questionnaires

Substances

  • Anti-HIV Agents